BAP1-Inactivated Melanocytic Tumors With Distinctive p16-Negative Clonal Growth and Liver Metastases

BAP1-inactivated melanocytic tumor (BIMT) represents a distinct subtype of melanocytoma, with characteristic morphologic features. These lesions are associated with inactivation of the BAP1 tumor suppressor gene. Although there are frequently histologic features that might otherwise cause concern for malignancy, including enlarged cells with nuclear variability, prominent nucleoli, and a lymphocytic inflammatory infiltrate, empirical data suggest that the majority behave in a clinically benign fashion. We report 2 cases of cutaneous BIMT with a distinctive morphologic pattern of clonal expansion with p16 loss. In both cases, there was liver metastasis after complete excision, in the absence of locoregional recurrence. These rare cases highlight the possibility of a distinct pathway of malignant progression in BIMT.

Authors

Institutions

Publication Details

Journal
American Journal of Dermatopathology
Published
2025-11-14
DOI
https://doi.org/10.1097/dad.0000000000003151
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BAP1-Inactivated Melanocytic Tumors With Distinctive p16-Negative Clonal Growth and Liver Metastases

Sarah Shepard, Nima Mesbah Ardakani, Nathan T. Harvey, Benjamin A. Wood et al.
American Journal of Dermatopathology
Cutaneous Melanoma Detection and Management
article

BAP1-Inactivated Melanocytic Tumors With Distinctive p16-Negative Clonal Growth and Liver Metastases

Sarah Shepard, Nima Mesbah Ardakani, Nathan T. Harvey, Benjamin A. Wood, Craig James
article en

Abstract

BAP1-inactivated melanocytic tumor (BIMT) represents a distinct subtype of melanocytoma, with characteristic morphologic features. These lesions are associated with inactivation of the BAP1 tumor suppressor gene. Although there are frequently histologic features that might otherwise cause concern for malignancy, including enlarged cells with nuclear variability, prominent nucleoli, and a lymphocytic inflammatory infiltrate, empirical data suggest that the majority behave in a clinically benign fashion. We report 2 cases of cutaneous BIMT with a distinctive morphologic pattern of clonal expansion with p16 loss. In both cases, there was liver metastasis after complete excision, in the absence of locoregional recurrence. These rare cases highlight the possibility of a distinct pathway of malignant progression in BIMT.

American Journal of DermatopathologyVol. 48(2)
South Australia Pathology (AU), The University of Western Australia (AU), Pathwest Laboratory Medicine (AU)
Openalex Percentile: Top 53%
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.